Interneuron Pharmaceutical
Executive Summary
Opens Cambridge, Mass. headquarters and completes $ 2.4 mil. private placement through New York banker D. H. Blair & Co. Interneuron was formed in March; private placement will be used to fund staff and neurologic and psychiatric drug research. MIT Clinical Research Center Director Richard Wurtman chairs firm's scientific advisory board. Firm also names former Hoechst-Roussel Pharmaceuticals research director Stuart Fielding, PhD, to VP-research and development.